KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,742 | -25.1% | 1,300 | 0.0% | 0.00% | – |
| Q2 2023 | $2,327 | -25.2% | 1,300 | +62.5% | 0.00% | – |
| Q1 2023 | $3,112 | +14.4% | 800 | 0.0% | 0.00% | – |
| Q4 2022 | $2,720 | -32.0% | 800 | 0.0% | 0.00% | – |
| Q3 2022 | $4,000 | 0.0% | 800 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 800 | 0.0% | 0.00% | – |
| Q4 2021 | $5,000 | -68.8% | 800 | -71.5% | 0.00% | -100.0% |
| Q3 2021 | $16,000 | -38.5% | 2,805 | +12.0% | 0.00% | 0.0% |
| Q2 2021 | $26,000 | -51.9% | 2,505 | -50.9% | 0.00% | -50.0% |
| Q1 2021 | $54,000 | – | 5,105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |